All stock lists
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.78
Insider Score
––Not scored
PCSA Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
PCSA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 301.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -301.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 1.69 M | 1.52 M | 1.59 M | 1.83 M | 1.50 M | 1.26 M |
| R&D Expense | 649.88 K | 1.81 M | 2.11 M | 1.66 M | 2.45 M | 1.59 M |
| Operating Expenses | 2.34 M | 3.33 M | 3.70 M | 3.49 M | 3.95 M | 2.85 M |
| Operating Income | -2.34 M | -3.33 M | -3.70 M | -3.49 M | -3.95 M | -2.85 M |
| Pretax Income | -3.27 M | -3.38 M | -3.36 M | -3.44 M | -3.93 M | -2.83 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -3.27 M | -3.38 M | -3.36 M | -3.44 M | -3.93 M | -2.83 M |
| EPS (Basic) | -1.19 | -1.29 | -1.31 | -1.81 | -6.25 | -7.44 |
| EPS (Diluted) | -1.19 | -1.29 | -1.31 | -1.81 | -6.25 | -7.44 |
| Shares Outstanding | 2.75 M | 2.62 M | 2.57 M | 1.90 M | 622.77 K | 381.07 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.